Exact Sciences [EXAS] vs Waters [WAT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Exact Sciences Corp wins in 5 metrics, Waters Corporation wins in 14 metrics, with 0 ties. Waters Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Exact Sciences Corp Waters Corporation Better
P/E Ratio (TTM) -95.37 28.90 Waters Corporation
Price-to-Book Ratio 8.34 7.24 Waters Corporation
Debt-to-Equity Ratio 105.57 60.28 Waters Corporation
PEG Ratio 55.22 -9.39 Exact Sciences Corp
EV/EBITDA 302.23 28.78 Waters Corporation
Profit Margin (TTM) -6.40% 20.30% Waters Corporation
Operating Margin (TTM) -9.28% 33.76% Waters Corporation
EBITDA Margin (TTM) N/A 33.76% N/A
Return on Equity -8.66% 29.28% Waters Corporation
Return on Assets (TTM) -1.59% 11.52% Waters Corporation
Free Cash Flow (TTM) $356.78M $539.81M Waters Corporation
1-Year Return 140.29% 3.87% Exact Sciences Corp
Price-to-Sales Ratio (TTM) 6.17 9.65 Exact Sciences Corp
Enterprise Value $21.60B $31.49B Waters Corporation
EV/Revenue Ratio 6.65 9.95 Exact Sciences Corp
Gross Profit Margin (TTM) 70.11% 61.08% Exact Sciences Corp
Revenue per Share (TTM) $17 $53 Waters Corporation
Earnings per Share (Diluted) $-1.10 $10.77 Waters Corporation
Beta (Stock Volatility) 1.44 1.20 Waters Corporation
Short % of Float 3.92% 3.38% Waters Corporation

Exact Sciences Corp vs Waters Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Exact Sciences Corp0.00%1.02%1.47%3.27%100.17%3.12%
Waters Corporation0.63%-1.54%8.67%23.36%-7.18%-6.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Exact Sciences Corp140.29%54.71%-20.87%1,407.33%1,337.12%3,317.26%
Waters Corporation3.87%32.07%3.74%165.28%286.07%736.74%

Performance & Financial Health Analysis: Exact Sciences Corp vs Waters Corporation

MetricEXASWAT
Market Information
Market Cap i$20.03B$30.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,743,583809,747
90 Day Avg. Volume i2,715,014944,136
Last Close$104.91$357.76
52 Week Range$38.81 - $104.98$275.05 - $414.15
% from 52W High-0.07%-13.62%
All-Time High$159.54 (Jan 25, 2021)$428.22 (Sep 06, 2021)
% from All-Time High-34.24%-16.45%
Growth Metrics
Quarterly Revenue Growth0.23%0.07%
Quarterly Earnings Growth0.23%-0.03%
Financial Health
Profit Margin (TTM) i-0.06%0.20%
Operating Margin (TTM) i-0.09%0.34%
Return on Equity (TTM) i-0.09%0.29%
Debt to Equity (MRQ) i105.5760.28
Cash & Liquidity
Book Value per Share (MRQ)$12.58$43.01
Cash per Share (MRQ)$5.05$5.99
Operating Cash Flow (TTM) i$491.44M$652.56M
Levered Free Cash Flow (TTM) i$281.87M$427.16M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Exact Sciences Corp vs Waters Corporation

MetricEXAS (Apr 07, 2026)WAT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-95.3728.90
Forward P/E i55.2219.04
PEG Ratio i55.22-9.39
Price to Sales (TTM) i6.179.65
Price to Book (MRQ) i8.347.24
Market Capitalization
Market Capitalization i$20.03B$30.55B
Enterprise Value i$21.60B$31.49B
Enterprise Value Metrics
Enterprise to Revenue i6.659.95
Enterprise to EBITDA i302.2328.78
Risk & Other Metrics
Beta i1.441.20
Book Value per Share (MRQ) i$12.58$43.01

Financial Statements Comparison: Exact Sciences Corp vs Waters Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEXAS (2025)WAT (2025)
Revenue/Sales i3.25B3.17B
Cost of Goods Sold i984.24M1.29B
COGS % of Revenue i30.3%40.7%
Gross Profit i2.26B1.88B
Gross Margin i69.7%59.3%
Research & Development i523.00M195.71M
Operating Income (EBIT) i-199.10M802.59M
Operating Margin i-6.1%25.4%
EBITDA i17.87M1.03B
EBITDA Margin i0.6%32.6%
Pre-Tax Income i-203.89M754.88M
Pre-Tax Income % of Revenue i-6.3%23.8%
Income Tax i4.06M112.25M
Income Tax % of Revenue i0.1%3.5%
Net Income (Profit) i-207.95M642.63M
Profit Margin i-6.4%20.3%

Balance Sheet & Liquidity Metrics

MetricEXAS (2025)WAT (2025)
Cash & Equivalents i956.00M587.83M
Total Current Assets i1.56B2.15B
Total Current Assets % of Revenue i47.9%67.8%
Total Current Liabilities i641.15M1.24B
Total Current Liabilities % of Revenue i19.7%39.2%
Long-Term Debt i2.49B999.99M
Long-Term Debt % of Revenue i76.7%31.6%
Total Shareholders Equity i2.40B2.56B
Retained Earnings i-4.71B10.43B
Retained Earnings % of Revenue i-144.9%329.6%
Property, Plant & Equipment i122.33M824.49M

Cash Flow Statement Comparison

MetricEXAS (2025)WAT (2025)
Operating Cash Flow i273.28M652.56M
Operating Cash Flow % of Revenue i8.4%20.6%
Capital Expenditures i-134.66M-112.75M
Free Cash Flow i356.78M539.81M
FCF Margin i11.0%17.1%
Debt Repayment i-249.17M-290.00M
Common Stock Repurchase iN/A-14.67M

Short Interest & Institutional Ownership Analysis

MetricEXASWAT
Shares Short i7.40M3.32M
Short Ratio i3.232.98
Short % of Float i3.92%3.38%
Shares Outstanding i190.80M59.55M
Float Shares i188.45M97.96M
% Held by Insiders i1.23%0.11%
% Held by Institutions i86.48%63.35%
% Held by Public i12.29%36.54%

Dividend Analysis & Yield Comparison: Exact Sciences Corp vs Waters Corporation

MetricEXASWAT
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A